Literature DB >> 12201079

Modulite: a means of designing the aerosols generated by pressurized metered dose inhalers.

D Ganderton1, D Lewis, R Davies, B Meakin, G Brambilla, T Church.   

Abstract

Although popular, the pressurized metered dose inhaler generates coarse, fast moving clouds so that the fraction reaching the lung is small. These shortcomings can be redressed by Modulite which permutes the following variables: the non-volatile components of a solution formula, the actuator orifice geometry, the volume of the metered solution and the vapour pressure of the propellants. This permits the design of aerosols with chosen particle size and plume speed. This facilitates co-ordination of dose generation with inspiration, reduces oropharyngeal deposition and provides a mechanism for targeting drug delivery to different parts of the lung. These principles are exemplified by designing an HFA-propelled beclometasone dipropionate product which closely matches existing products which use chlorofluorocarbons.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12201079     DOI: 10.1016/s0954-6111(02)80018-x

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  9 in total

1.  Spray pattern analysis for metered dose inhalers: effect of actuator design.

Authors:  Hugh Smyth; Geoff Brace; Tony Barbour; Jim Gallion; Joe Grove; Anthony J Hickey
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.200

2.  Effect of AeroChamber Plus™ on the lung and systemic bioavailability of beclometasone dipropionate/formoterol pMDI.

Authors:  Dave Singh; Sara Collarini; Gianluigi Poli; Daniela Acerbi; Alessio Amadasi; Antonio Rusca
Journal:  Br J Clin Pharmacol       Date:  2011-12       Impact factor: 4.335

3.  Urinary pharmacokinetic methodology to determine the relative lung bioavailability of inhaled beclometasone dipropionate.

Authors:  Amira S A Said; Lindsay P Harding; Henry Chrystyn
Journal:  Br J Clin Pharmacol       Date:  2012-09       Impact factor: 4.335

4.  Beclometasone dipropionate/formoterol: in an HFA-propelled pressurised metered-dose inhaler.

Authors:  Sohita Dhillon; Gillian M Keating
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 5.  Pharmacokinetic and pharmacodynamic properties of inhaled beclometasone dipropionate delivered via hydrofluoroalkane-containing devices.

Authors:  Eric Derom; Romain A Pauwels
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

6.  Comparison of bronchoprotective and bronchodilator effects of a single dose of formoterol delivered by hydrofluoroalkane and chlorofluorocarbon aerosols and dry powder in a double blind, placebo-controlled, crossover study.

Authors:  C M Houghton; S J Langley; S D Singh; J Holden; A P Monici Preti; D Acerbi; G Poli; A Woodcock
Journal:  Br J Clin Pharmacol       Date:  2004-10       Impact factor: 4.335

Review 7.  Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD.

Authors:  Nicola Scichilone; Alida Benfante; Luca Morandi; Federico Bellini; Alberto Papi
Journal:  Patient Relat Outcome Meas       Date:  2014-11-27

8.  Lung penetration and patient adherence considerations in the management of asthma: role of extra-fine formulations.

Authors:  Nicola Scichilone; Mario Spatafora; Salvatore Battaglia; Rita Arrigo; Alida Benfante; Vincenzo Bellia
Journal:  J Asthma Allergy       Date:  2013-01-09

9.  The challenge of delivering therapeutic aerosols to asthma patients.

Authors:  Federico Lavorini
Journal:  ISRN Allergy       Date:  2013-08-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.